Stay updated on Lumasiran in Advanced Primary Hyperoxaluria Type 1 Clinical Trial
Sign up to get notified when there's something new on the Lumasiran in Advanced Primary Hyperoxaluria Type 1 Clinical Trial page.

Latest updates to the Lumasiran in Advanced Primary Hyperoxaluria Type 1 Clinical Trial page
- CheckyesterdayChange DetectedA site-wide NIH notice was added explaining that federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence”.SummaryDifference0.3%

- Check8 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1; the study record history remains unchanged.SummaryDifference0.0%

- Check35 days agoChange DetectedRevision label in the page history has been updated to v3.7.0, replacing the previous v3.6.6. This indicates a minor site update to the record history page, without changes to the study data or content visible to users.SummaryDifference0.0%

- Check56 days agoChange DetectedThe study record history now adds a revision entry for v3.6.6 and removes the previous v3.6.5 entry, signaling an updated patch to the record.SummaryDifference0.0%

- Check77 days agoChange DetectedA new revision entry, v3.6.5, was added and the previous v3.6.4 entry was removed. This reflects a small platform update to the study record history rather than a change to the study data.SummaryDifference0.0%

Stay in the know with updates to Lumasiran in Advanced Primary Hyperoxaluria Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumasiran in Advanced Primary Hyperoxaluria Type 1 Clinical Trial page.